Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $1,564,771 (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 12.5%
Value ($000) $195,514 Shares 2,212,950 Est. Cost $83.16 Unrealized -0.8%
ABIOMED INC 11.9%
Value ($000) $186,421 Shares 519,033 Est. Cost $81.43 Unrealized
INSM INSMED INC 10.5%
Value ($000) $164,140 Shares 6,025,706 Est. Cost $17.79 Unrealized +60.7%
UTHR UNITED THERAPEUTICS CORP 9.5%
Value ($000) $148,491 Shares 687,206 Est. Cost $89.23 Unrealized +120.0%
FOLD AMICUS THERAPEUTICS INC 7.5%
Value ($000) $116,817 Shares 10,114,043 Est. Cost $9.52 Unrealized +17.1%
STAA STAAR SURGICAL CO 6.7%
Value ($000) $104,129 Shares 1,140,511 Est. Cost $14.28 Unrealized +651.5%
BIIB BIOGEN INC 5.9%
Value ($000) $92,369 Shares 385,000 Est. Cost $264.06 Unrealized -2.6%
PRTA PROTHENA CORP PLC 5.3%
Value ($000) $83,253 Shares 1,685,282 Est. Cost $21.46 Unrealized +158.4%
REVANCE THERAPEUTICS INC 4.6%
Value ($000) $71,308 Shares 4,369,366 Est. Cost $22.01 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 3.5%
Value ($000) $54,566 Shares 2,337,877 Est. Cost $33.89 Unrealized -40.7%
VNDA VANDA PHARMACEUTICALS INC 2.8%
Value ($000) $44,469 Shares 2,834,244 Est. Cost $11.21 Unrealized +55.4%
EHTH EHEALTH INC 2.6%
Value ($000) $41,197 Shares 1,615,570 Est. Cost $60.36 Unrealized -45.0%
ALGN ALIGN TECHNOLOGY INC 2.3%
Value ($000) $36,411 Shares 55,405 Est. Cost $114.31 Unrealized +462.4%
KARYOPHARM THERAPEUTICS INC 2.2%
Value ($000) $35,175 Shares 5,470,452 Est. Cost $16.61 Unrealized
SAGE THERAPEUTICS INC 2.1%
Value ($000) $33,255 Shares 781,730 Est. Cost $47.83 Unrealized
GRITSTONE ONCOLOGY INC 1.9%
Value ($000) $30,302 Shares 2,356,282 Est. Cost $9.42 Unrealized
GOSS GOSSAMER BIO INC 1.3%
Value ($000) $20,052 Shares 1,772,950 Est. Cost $11.85 Unrealized +0.3%
ALKS ALKERMES PLC 1.1%
Value ($000) $17,543 Shares 754,200 Est. Cost $22.36 Unrealized +17.6%
ANAB ANAPTYSBIO INC 1.0%
Value ($000) $15,172 Shares 436,592 Est. Cost $19.06 Unrealized +66.4%
EPIZYME INC 0.9%
Value ($000) $13,713 Shares 5,485,213 Est. Cost $14.39 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value ($000) $13,110 Shares 598,900 Est. Cost $16.84 Unrealized +9.7%
KEZAR LIFE SCIENCES INC 0.7%
Value ($000) $10,972 Shares 656,200 Est. Cost $5.16 Unrealized
CLOVIS ONCOLOGY INC 0.7%
Value ($000) $10,834 Shares 3,997,826 Est. Cost $47.56 Unrealized
CYTK CYTOKINETICS INC 0.4%
Value ($000) $5,638 Shares 123,686 Est. Cost $6.71 Unrealized +474.8%
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value ($000) $5,155 Shares 166,069 Est. Cost $23.56 Unrealized +19.6%
ZOGENIX INC 0.2%
Value ($000) $2,987 Shares 183,800 Est. Cost $20.95 Unrealized
MAGENTA THERAPEUTICS INC 0.1%
Value ($000) $1,915 Shares 432,300 Est. Cost $7.38 Unrealized
NVAX NOVAVAX INC 0.1%
Value ($000) $1,788 Shares 12,500 Est. Cost $171.82 Unrealized 0.0%
RIGEL PHARMACEUTICALS INC 0.1%
Value ($000) $1,729 Shares 652,395 Est. Cost $3.40 Unrealized
AZN ASTRAZENECA PLC-SPONS ADR 0.1%
Value ($000) $1,704 Shares 29,260 Est. Cost $60.06 Unrealized
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value ($000) $1,032 Shares 64,700 Est. Cost $15.56 Unrealized 0.0%
ALIMERA SCIENCES INC 0.1%
Value ($000) $1,031 Shares 200,919 Est. Cost $6.30 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.1%
Value ($000) $815 Shares 341,030 Est. Cost $13.76 Unrealized -70.4%
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value ($000) $643 Shares 160,800 Est. Cost $7.10 Unrealized +7.5%
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value ($000) $516 Shares 27,100 Est. Cost $39.74 Unrealized -28.6%
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $372 Shares 31,330 Est. Cost $15.48 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value ($000) $233 Shares 24,500 Est. Cost $27.01 Unrealized -47.8%